Small shareholder here. National Bank of Canada put in a price target of C$3.25. About A$4.10. The link is available on the ceo.ca forum.
NEU Neuren Pharmaceuticals dips after pediatric Angelman Syndrome Phase 2 trial results fail to impress
Week 32 Wrap: AI is clearly overhyped – but did we see ‘bubble’ burst already? Plus RBA decision; Japan’s wild week & Google ruling